A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production

Journal of Virology

Volumn 81, Issue 3, 2007, Pages 1528-1533

  Hamano, Takaichi ^a   Matsuo, Kazuhiro ^a   Hibi, Yurina ^b   Victoriano, Ann Florence B ^b   Takahashi, Naoko ^b   Mabuchi, Yosio ^b   Soji, Tsuyoshi ^b   Irie, Sninji ^c   Sawanpanyalert, Pathom ^d   Yanai, Hideki ^e   Hara, Takashi ^a   Yamazaki, Shudo ^a   Yamamoto, Naoki ^a   Okamoto, Takashi ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c Shiroyama Hills   (Japan)

^d MINISTRY OF PUBLIC HEALTH   (Thailand)

^e RIT JATA   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; NUCLEOTIDE; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG USE; GENE MUTATION; HIGH RISK POPULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; THAILAND; VIRION; VIROGENESIS; VIRUS MORPHOGENESIS; VIRUS REPLICATION;

DNA, VIRAL; GENES, GAG; HIV-1; HUMANS; MUTATION; NUCLEOTIDES; VIRION;

AVIAN ENCEPHALOMYELITIS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33846519298     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01596-06     Document Type: Article

References (26)

1. Bennett, R. P., T. D. Nelle, and J. W. Wills. 1993. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins. J. Virol. 67:6487-6498.
2. Beretta, A., S. H. Weiss, G. Rappocciolo, R. Mayur, C. De Santis, J. Quirinale, A. Cosma, P. Robbioni, G. M. Shearer, J. A. Berzofsky, M. L. Villa, A. G. Siccardi, and M. Clerici. 1996. Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drag users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope. J. Infect. Dis. 173:472-476.
3. Bryson, Y. J., S. Pang, L. S. Wei, R. Dickover, A. Diagne, and I. S. Chen. 1995. Clearance of HIV infection in a perinatally infected infant. N. Engl. J. Med. 332:833-838.
4. Cannon, P. M., S. Matthews, N. Clark, E. D. Byles, O. Iourin, D. J. Hockley, S. M. Kingsman, and A. J. Kingsman. 1997. Structure-function studies of the human immunodeficiency virus type 1 matrix protein, pl7. J. Virol. 71:3474-3483.
5. Fowke, K. R., N. J. Nagelkerke, J. Kimani, J. N. Simonsen, A. O. Anzala, J. J. Bwayo, K. S. MacDonald, E. N. Ngugi, and F. A. Plummer. 1996. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348:1347-1351.
6. Freed, E. O. 2001. HIV-1 Replication. Somat. Cell Mol. Genet. 26:13-33.
7. Hamano, T., P. Sawanpanyalert, H. Vanai. S. Piyaworawong, T. Hara, S. Sapsutthipas, J. Phromjai, S. Yamazaki, N. Yamamoto, P. Warachit, M. Honda, and K. Matsuo. 2004. Determination of HIV type 1 CRF01_AE gag p17 and env-V3 consensus sequence for HIV/AIDS vaccine design. AIDS Res. Hum. Retrovir. 20:337-340.
8. Huang, Y., W. A. Paxton, S. M. Wolinsky, A. U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N. R. Landau, J. Phair, D. D. Ho, and R. A. Koup. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-1243.
9. Jittiwutikarn, J., P. Sawanpanyalert, N. Pangsiveroj, and P. Satitvipawee. 2000. HIV incidence rates among drug users in northern Thailand, 1993-7. Epidemiol. Infect. 125:153-158.
10. Kaul, R., T. Dong, F. A. Plummer, J. Kimani, T. Rostron, P. Kiama, E. Njagi, E. Irungu, B. Farah, J. Oyugi, R. Chakraborty, K. S. MacDonald, J. J. Bwayo, A. McMichael, and S. L. Rowland-Jones. 2001. CD8+ lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J. Clin. Investig. 107:1303-1310.
11. 11. Kober, B. T., S. Osmanov, J. Esparza, and G. Myers. 1994. The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence nomenclature. WHO Network for HIV Isolation and Characterization. AIDS Res. Hum. Retrovir. 10:1355-1358.
12. Kusagawa, S., H. Sato, Y. Tomita, M. Tatsumi, K. Kalo, K. Motomura, R. Yang, and Y. Takebe. 2002. Isolation and characterization of replication-competent molecular DNA clones of HIV type 1 CRF01_AE with different coreceptor usage. AIDS Res. Hum. Retrovir. 18:115-1227
13. Langlade-Demoyen, P., N. Ngo-Giang-Huong, F. Ferchal, and E. Oksenhendler. 1994. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J. Clin. Investig. 93:1293-1297.
14. Learmont, J. C., A. F. Geczy, J. Mills, L. J. Ashton, C. H. Raynes-Greenow, R. J. Garsia, W. B. Dyer, L. McIntyre, R. B. Oelrichs, D. I. Rhodes, N. J. Deacon, and J. S. Sullivan. 1999. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. N. Engl. J. Med. 340:1715-1722.
15. Leitner, T., D. Escanilla, S. Marquina, J. Wahlberg, C. Brostrom, H. B. Hansson, M. Uhlen, and J. Albert. 1995. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden. Virology 209:136-146.
16. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377.
17. Rein, A., L. E. Henderson, and J. G. Levin. 1998. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem. Sci. 23:297-301.
18. Roldan, A., R. S. Russell, B. Marchand, M. Gotte, C. Liang, and M. A. Wainberg. 2004. In vitro identification and characterization of an early complex linking HIV-1 genomic RNA recognition and PrSSGag multimerization. J. Biol. Chem. 279:39886-39894.
19. Roques, P. A., G. Gras, F. Parnet-Mathieu, A. M. Mabondzo, C. Dollfus, R. Narwa, D. Marce, J. Tranchot-Diallo, F. Herve, G. Lasfargues, C. Courpotin, and D. Dorment. 1995. Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS 9:F19-F26.
20. Rowland-Jones, S. L., D. F. Nixon, M. C. Aldhous, F. Gotch, K. Ariyoshi, N. Hallam, J. S. Kroll, K. Froebel, and A. McMichael. 1993. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 341:860-861.
21. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, and M. Takiguchi. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
22. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapouméroulie, J. Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy, M. Georges, T. Imai, S. Rana, Y. Yi, R. J. Smyth, R. G. Collman, R. W. Doms, G. Vassart, and M. Parmentier. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
23. Skurnick, J. H., P. Palumbo, A. DeVico, B. L. Shacklett, F. T. Valentine, M. Merges, R. Kamin-Lewis, J. Mestecky, T. Denny, G. K. Lewis, J. Lloyd, R. Praschunus, A. Baker, D. F. Nixon, S. Stranford, R. Gallo, S. H. Vermund, and D. B. Louria. 2002. Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. J. Infect. Dis. 185:428-438.
24. Takada, N., T. Sanda, H. Okamoto, J. P. Yang, K. Asamitsu, L. Sarol, G. Kimura, H. Uranishi, T. Tetsuka, and T. Okamoto. 2002. RelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-κB and Sp1 actions. J. Virol. 76:8019-8030.
25. Traber, K. E., H. Okamoto, C. Kurono, M. Baba, C. Saliou, T. Soji, L. Packer, and T. Okamoto. 1999. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. Int. Immunol. 11:143-150.
26. Zhu, T., L. Corey, Y. Hwangbo, J. M. Lee, G. H. Learn, J. I. Mullins, and M. J. McElrath. 2003. Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J. Virol. 77:6108-6116.